脓毒症住院合并与不合并心房颤动的趋势与结局:全国住院患者分析
该回顾性队列研究利用美国全国住院患者样本数据库(2010-2014年),纳入5,808,166例主要出院诊断为脓毒症的住院患者,其中19.4%(1,126,433例)合并心房颤动。合并心房颤动组患者年龄更大(中位79岁 vs 67岁)、白人比例更高(80.9% vs 68.8%)、男性更多(51.1% vs 47.5%)、住院时间更长(中位6天 vs 5天)、住院费用更高(中位44,765美元 vs 35,737美元),全因死亡率显著更高(18.4% vs 11.9%,p=0.001)。2010至2014年间,脓毒症合并心房颤动组的全因死亡率(20.4% vs 16.6%)和住院时间(中位7天 vs 6天)下降,但住院费用上升(中位41,783美元 vs 46,251美元)。心房颤动-脓毒症队列中死亡的最强预测因素为非洲裔美国人种族、女性、高龄和存在内科合并症。
要点
- 脓毒症住院中合并心房颤动者占19.4%(1,126,433/5,808,166),全因死亡率18.4% vs 不合并者11.9%(p=0.001)。
- 合并心房颤动的脓毒症患者年龄更大(中位79岁 vs 67岁)、住院时间更长(中位6天 vs 5天)、住院费用更高(中位44,765美元 vs 35,737美元)。
- 2010至2014年间,合并心房颤动组全因死亡率由20.4%降至16.6%,住院时间中位由7天降至6天,但住院费用中位由41,783美元升至46,251美元。
- 心房颤动-脓毒症队列中死亡的最强预测因素为非洲裔美国人种族、女性、高龄和存在内科合并症。
- 研究期间脓毒症及脓毒症合并心房颤动住院呈上升趋势,但死亡率和死亡比值比逐渐下降。
适用人群与场景
- 美国全国住院患者样本数据库(2010-2014年)中主要出院诊断为脓毒症的住院患者,合并与不合并心房颤动者。
诊断标准与关键阈值
- 使用经先前验证的国际疾病分类第九版临床修订代码(ICD-9-CM)识别主要出院诊断为脓毒症合并与不合并心房颤动。
研究设计与关键结果
- 回顾性队列研究,基于美国全国住院患者样本数据库(2010-2014年),共5,808,166例主要诊断为脓毒症的住院,其中19.4%(1,126,433例)合并心房颤动。
- 合并心房颤动组 vs 不合并组:中位年龄79岁(IQR 70-86)vs 67岁(IQR 53-79),p<0.001;白人80.9% vs 68.8%,p<0.001;男性51.1% vs 47.5%,p<0.001。
- 合并心房颤动组 vs 不合并组:中位住院时间6天(IQR 4-11)vs 5天(IQR 3-9),p<0.001;中位住院费用44,765美元(IQR 23,234-88,657)vs 35,737美元(IQR 18,767-72,220),p<0.001。
- 合并心房颤动组全因死亡率18.4% vs 不合并组11.9%,p=0.001。
- 2010至2014年间,合并心房颤动组全因死亡率20.4% vs 16.6%、住院时间中位7天(IQR 4-11)vs 6天(IQR 4-10)下降,住院费用中位41,783美元(IQR 21,430-84,465)vs 46,251美元(IQR 24,157-89,995)上升。
- 心房颤动-脓毒症队列中死亡的最强预测因素为非洲裔美国人种族、女性、高龄和存在内科合并症。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脓毒症住院中合并心房颤动是预后不良和死亡率升高的标志。
- 研究期间脓毒症及脓毒症合并心房颤动住院呈上升趋势,但死亡率和死亡比值比逐渐下降。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Atrial fibrillation is frequently seen in sepsis-related hospitalizations. However, large-scale contemporary data from the United States comparing outcomes among sepsis-related hospitalizations with versus without atrial fibrillation are limited. The aim of our study was to assess the frequency of atrial fibrillation and its impact on outcomes of sepsis-related hospitalizations.
DESIGN: Retrospective cohort study.
SETTING: The National Inpatient Sample databases (2010-2014).
PATIENTS: Primary discharge diagnosis of sepsis with and without atrial fibrillation were identified using prior validated International Classification of Diseases, 9th Edition, Clinical Modification codes.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Overall, 5,808,166 hospitalizations with the primary diagnosis of sepsis, of which 19.4% (1,126,433) were associated with atrial fibrillation. The sepsis-atrial fibrillation cohort consisted of older (median [interquartile range] age of 79 yr [70-86 yr] vs 67 yr [53-79 yr]; p < 0.001) white (80.9% vs 68.8%; p < 0.001) male (51.1% vs 47.5%; p < 0.001) patients with an extended length of stay (median [interquartile range] 6 d [4-11 d] vs 5 d [3-9 d]; p < 0.001) and higher hospitalization charges (median [interquartile range] $44,765 [$23,234-$88,657] vs $35,737 [$18,767-$72,220]; p < 0.001) as compared with the nonatrial fibrillation cohort. The all-cause mortality rate in the sepsis-atrial fibrillation cohort was significantly higher (18.4% and 11.9%; p = 0.001) as compared with those without atrial fibrillation. Although all-cause mortality (20.4% vs 16.6%) and length of stay (median [interquartile range] 7 d [4-11 d] vs 6 d [4-10 d]) decreased between 2010 and 2014, hospitalization charges increased (median [interquartile range] $41,783 [$21,430-$84,465] vs $46,251 [$24,157-$89,995]) in the sepsis-atrial fibrillation cohort. The greatest predictors of mortality in the atrial fibrillation-sepsis cohort were African American race, female gender, advanced age, and the presence of medical comorbidities.
CONCLUSIONS: The presence of atrial fibrillation among sepsis-related hospitalizations is a marker of poor prognosis and increased mortality. Although we observed rising trends in sepsis and sepsis-atrial fibrillation-related hospitalizations during the study period, the rate and odds of mortality progressively decreased.
参考来源
- Desai R, Hanna B, Singh S, et al. Trends and Outcomes in Sepsis Hospitalizations With and Without Atrial Fibrillation: A Nationwide Inpatient Analysis. Crit Care Med. 2019. PMID: 31094740. doi:10.1097/CCM.0000000000003806
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。